tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Butler, 241 are a BUY (93.77%), 14 are a HOLD (5.45%), 2 are a SELL (0.78%).
Analyst Jason Butler, currently employed at JMP, carries an average stock price target met ratio of 38.86% that have a potential upside of 55.3% achieved within 217 days.
Jason Butler’s has documented 495 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on CYTK, Cytokinetics at 22-Dec-2025.
Analyst best performing recommendations are on TRVN (TREVENA).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS) at 2/24/2021. The price target of $48 was fulfilled within 1 day with a profit of $3.45 (6.71%) receiving and performance score of 67.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Dec-2021
$23
$-0.46 (-1.96%)
$22
5 days ago
(06-Feb-2026)
16/17 (94.12%)
$-0.46 (-1.96%)
89
Buy Since 26-Jun-2025
$31
$7.54 (32.14%)
$32
8 days ago
(03-Feb-2026)
0/5 (0%)
$4.87 (18.64%)
Buy Since 21-Oct-2025
$36
$12.54 (53.45%)
$33
1 months 5 days ago
(06-Jan-2026)
0/2 (0%)
$9.06 (33.63%)
Buy Since 17-Oct-2023
$40
$16.54 (70.50%)
$39
1 months 5 days ago
(06-Jan-2026)
2/7 (28.57%)
$13.06 (48.48%)
467
Hold Since 03-Nov-2022
$25
$1.54 (6.56%)
2 months ago
(11-Dec-2025)
18/21 (85.71%)
$-1.68 (-6.30%)
118
Which stock is Jason Butler is most bullish on?
Which stock is Jason Butler is most reserved on?
What Year was the first public recommendation made by Jason Butler?
